222 related articles for article (PubMed ID: 28657205)
1. MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers.
Golabchi K; Soleimani-Jelodar R; Aghadoost N; Momeni F; Moridikia A; Nahand JS; Masoudifar A; Razmjoo H; Mirzaei H
J Cell Physiol; 2018 Apr; 233(4):3016-3023. PubMed ID: 28657205
[TBL] [Abstract][Full Text] [Related]
2. Serum exosomal miRNA as biomarkers for Retinoblastoma.
Ravishankar H; Mangani AS; Phoebe Moses GL; Mani SP; Parameswaran S; Khetan V; Ganesan S; Krishnakumar S
Exp Eye Res; 2020 Oct; 199():108184. PubMed ID: 32795526
[TBL] [Abstract][Full Text] [Related]
3. The functional role of circular RNAs in the pathogenesis of retinoblastoma: a new potential biomarker and therapeutic target?
Karami Fath M; Pourbagher Benam S; Kouhi Esfahani N; Shahkarami N; Shafa S; Bagheri H; Shafagh SG; Payandeh Z; Barati G
Clin Transl Oncol; 2023 Aug; 25(8):2350-2364. PubMed ID: 37000290
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs and exosomes in depression: Potential diagnostic biomarkers.
Tavakolizadeh J; Roshanaei K; Salmaninejad A; Yari R; Nahand JS; Sarkarizi HK; Mousavi SM; Salarinia R; Rahmati M; Mousavi SF; Mokhtari R; Mirzaei H
J Cell Biochem; 2018 May; 119(5):3783-3797. PubMed ID: 29236313
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNAs involved in retinoblastoma.
Nasrolahi A; Azizidoost S; Radoszkiewicz K; Najafi S; Ghaedrahmati F; Sheykhi-Sabzehpoush M; Poodineh J; Hajizadeh M; Anbiyaiee A; Farzaneh M; Feghhi M
J Cancer Res Clin Oncol; 2023 Jan; 149(1):401-421. PubMed ID: 36305946
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑758 inhibits malignant progression of retinoblastoma by directly targeting PAX6.
Li J; You X
Oncol Rep; 2018 Sep; 40(3):1777-1786. PubMed ID: 30015924
[TBL] [Abstract][Full Text] [Related]
7. Expression profiles and prognostic value of miRNAs in retinoblastoma.
Delsin LEA; Salomao KB; Pezuk JA; Brassesco MS
J Cancer Res Clin Oncol; 2019 Jan; 145(1):1-10. PubMed ID: 30350021
[TBL] [Abstract][Full Text] [Related]
8. Circulating miRNome detection analysis reveals 537 miRNAS in plasma, 625 in extracellular vesicles and a discriminant plasma signature of 19 miRNAs in children with retinoblastoma from which 14 are also detected in corresponding primary tumors.
Castro-Magdonel BE; Orjuela M; Alvarez-Suarez DE; Camacho J; Cabrera-Muñoz L; Sadowinski-Pine S; Medina-Sanson A; Lara-Molina C; García-Vega D; Vázquez Y; Durán-Figueroa N; Orozco-Romero MJ; Hernández-Ángeles A; Ponce-Castañeda MV
PLoS One; 2020; 15(4):e0231394. PubMed ID: 32287312
[TBL] [Abstract][Full Text] [Related]
9. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
Yang Y; Mei Q
Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
[TBL] [Abstract][Full Text] [Related]
10. miRNAs as potential game-changers in retinoblastoma: Future clinical and medicinal uses.
Doghish AS; Moustafa HAM; Elballal MS; Sarhan OM; Darwish SF; Elkalla WS; Mohammed OA; Atta AM; Abdelmaksoud NM; El-Mahdy HA; Ismail A; Abdel Mageed SS; Elrebehy MA; Abdelfatah AM; Abulsoud AI
Pathol Res Pract; 2023 Jul; 247():154537. PubMed ID: 37216745
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.
Moridikia A; Mirzaei H; Sahebkar A; Salimian J
J Cell Physiol; 2018 Feb; 233(2):901-913. PubMed ID: 28092102
[TBL] [Abstract][Full Text] [Related]
12. State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia.
Mirzaei H; Fathullahzadeh S; Khanmohammadi R; Darijani M; Momeni F; Masoudifar A; Goodarzi M; Mardanshah O; Stenvang J; Jaafari MR; Mirzaei HR
J Cell Physiol; 2018 Feb; 233(2):888-900. PubMed ID: 28084621
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma.
Bai S; Tian B; Li A; Yao Q; Zhang G; Li F
Eye (Lond); 2016 Dec; 30(12):1630-1638. PubMed ID: 27518550
[TBL] [Abstract][Full Text] [Related]
14. A polymorphism in mir-34b/c as a potential biomarker for early onset of hereditary retinoblastoma.
Carvalho IN; Reis AH; Dos Santos AC; Vargas FR
Cancer Biomark; 2017; 18(3):313-317. PubMed ID: 28106538
[TBL] [Abstract][Full Text] [Related]
15. microRNA-144 functions as a diagnostic and prognostic marker for retinoblastoma.
Zheng Q; Zhu Q; Li C; Hao S; Li J; Yu X; Qi D; Pan Y
Clinics (Sao Paulo); 2020; 75():e1804. PubMed ID: 32844953
[TBL] [Abstract][Full Text] [Related]
16. Melanoma: Where we are and where we go.
Mohammadpour A; Derakhshan M; Darabi H; Hedayat P; Momeni M
J Cell Physiol; 2019 Apr; 234(4):3307-3320. PubMed ID: 30362507
[TBL] [Abstract][Full Text] [Related]
17. Translating microRNAs into biomarkers: What is new for pediatric cancer?
de Carvalho IN; de Freitas RM; Vargas FR
Med Oncol; 2016 May; 33(5):49. PubMed ID: 27085875
[TBL] [Abstract][Full Text] [Related]
18. MiR-22-3p targeting alpha-enolase 1 regulates the proliferation of retinoblastoma cells.
Liu Y; Li H; Liu Y; Zhu Z
Biomed Pharmacother; 2018 Sep; 105():805-812. PubMed ID: 29913409
[TBL] [Abstract][Full Text] [Related]
19. miRNome landscape analysis reveals a 30 miRNA core in retinoblastoma.
Castro-Magdonel BE; Orjuela M; Camacho J; García-Chéquer AJ; Cabrera-Muñoz L; Sadowinski-Pine S; Durán-Figueroa N; Orozco-Romero MJ; Velázquez-Wong AC; Hernández-Ángeles A; Hernández-Galván C; Lara-Molina C; Ponce-Castañeda MV
BMC Cancer; 2017 Jul; 17(1):458. PubMed ID: 28668075
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs horizon in retinoblastoma.
Mirakholi M; Mahmoudi T; Heidari M
Acta Med Iran; 2013; 51(12):823-9. PubMed ID: 24442535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
